Cytochrome P450S and uses thereof
AssigneeUniversity of Kentucky Research Foundation
InventorsJoseph Chappell, Lyle F. Ralston
Life of this patent
Estimating the term…
Abstract
The invention features isolated cytochrome P450 polypeptides and nucleic acid molecules, as well as expression vectors and transgenic plants containing these molecules. In addition, the invention features uses of such molecules in methods of increasing the level of resistance against a disease caused by a plant pathogen in a transgenic plant, in methods for producing altered compounds, for example, hydroxylated compounds, and in methods of producing isoprenoid compounds.
Claims20
A method for producing an isoprenoid compound, comprising:
- a) culturing a host cell under conditions suitable for expressing a first recombinant protein comprising an isoprenoid synthase and a second recombinant protein comprising a CYP71, CYP73, CYP82 or a CYP92 family cytochrome P450 polypeptide and under conditions for producing an isoprenoid compound, wherein:
- a CYP71, CYP73, CYP82, and CYP92 family cytochrome P450 polypeptide is encoded by nucleic acid that can be amplified with degenerate primers based on one of SEQ ID Nos. 26-29;
- the CYP71, CYP73, CYP82, and CYP92 family cytochrome P450 polypeptide has hydroxylase activity;
- and
- the first and second recombinant protein together catalyze the formation of an isoprenoid compound not normally produced by said host cell, wherein the cytochrome P450 polypeptide is selected from among polypeptides comprising at least 80% identity to polypeptides having an amino acid sequence set forth in SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9 and SEQ ID NO:11;
- and
- b) recovering the isoprenoid compound.
A method for producing an altered isoprenoid compound, comprising:
- contacting an isoprenoid compound with an isolated CYP71, CYP73, CYP82 or a CYP92 family cytochrome P450 polypeptide, wherein:
- a CYP71, CYP73, CYP82, and CYP92 family cytochrome P450 polypeptide is encoded by nucleic acid that can be amplified with degenerate primers based on one of SEQ ID Nos. 26-29;
- the P450 polypeptide catalyzes the formation of an isoprenoid compound, under conditions allowing for the dual hydroxylation, oxidation, demethylation, methylation, or any combination thereof of said compound to produce an altered isoprenoid compound;
- and
- recovering said altered isoprenoid compound, wherein the isolated P450 polypeptide comprises an amino acid sequence at least 80% identical to the amino acid sequence set forth in one of SEQ ID NOs:
- 1, 3, 5, 7, 9 and 11.
A host cell expressing a first recombinant protein comprising an isoprenoid synthase and a second recombinant protein comprising a CYP71, CYP73, CYP82 or a CYP92 family cytochrome P450 polypeptide, wherein:
- the second recombinant protein has hydroxylase activity;
- the first and second recombinant protein together catalyze the formation of an isoprenoid compound not normally produced by said host cell;
- the first and second recombinant proteins are heterologous to the host cell;
- and
- the cytochrome P450 polypeptide comprises an amino acid sequence at least 80% identical to the amino acid sequence set forth in SEQ ID NO:
- 1, SEQ ID NO:
- 3, SEQ ID NO:
- 5, SEQ ID NO:7, SEQ ID NO:
- 9 or SEQ ID NO:11.
Dependencies are inferred from the claim text.